Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy

BACKGROUND: The CRAFITY (C-reactive protein and alpha-fetoprotein in immunotherapy) score has demonstrated prognostic significance in hepatocellular carcinoma (HCC) patients undergoing immunotherapy. The study aimed to validate accuracy of CRAFITY score on predicting prognosis for patients with HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ze-Xin, Xu, Xiao-Yang, Wang, Ze, Huang, Jin-Tao, Li, Wan-Ci, Zhang, Shuai, Shen, Jian, Zhong, Bin-Yan, Zhu, Xiao-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676090/
https://www.ncbi.nlm.nih.gov/pubmed/38022730
http://dx.doi.org/10.2147/JHC.S439660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676090/
https://www.ncbi.nlm.nih.gov/pubmed/38022730
http://dx.doi.org/10.2147/JHC.S439660

Ejemplares similares